FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pricl Sabrina

Research Profile

Concepts & Ideas

Activities & Behaviors

Computer Simulation

Genes & Molecular Sequences

Molecular Structure

Chemicals & Drugs

Disorders

Gastrointestinal Stromal Tumors

Physiology

Occupations

Anatomy

Cell Line

Living Beings

RNA Viruses

Co-author Network

Publications

TOP 3
Daniel J Welsh; Paola Posocco; Pricl Sabrina; David K Smith
Self-assembled multivalent RGD-peptide arrays - morphological control and integrin binding.
Erik Laurini; Valentina Da Col; Bernhard Wünsch; Pricl Sabrina
Analysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor.
Daniela Rossi; Massimo Serra; Milena Sorrenti; Nicoletta Almirante; Stefania Brambilla; Laura Catenacci; Daniela Curti; Maurizio Fermeglia; Erik Laurini; Annamaria Marra; Marco Peviani; Pietro Picconi; Pricl Sabrina; Simona Collina
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pricl Sabrina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel J Welsh; Paola Posocco; Pricl Sabrina; David K Smith
Self-assembled multivalent RGD-peptide arrays - morphological control and integrin binding.
Organic & biomolecular chemistry 2013;11(19):3177-86.
2013: Erik Laurini; Valentina Da Col; Bernhard Wünsch; Pricl Sabrina
Analysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor.
Bioorganic & medicinal chemistry letters 2013;23(10):2868-71.
2013: Daniela Rossi; Massimo Serra; Milena Sorrenti; Nicoletta Almirante; Stefania Brambilla; Laura Catenacci; Daniela Curti; Maurizio Fermeglia; Erik Laurini; Annamaria Marra; Marco Peviani; Pietro Picconi; Pricl Sabrina; Simona Collina
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stability.
Bioorganic & medicinal chemistry 2013;21(9):2577-86.
2013: Stephen M Bromfield; Maurizio Fermeglia; Paola Posocco; Pricl Sabrina; Julián Rodríguez-López; David K Smith
A simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers.
Chemical communications (Cambridge, England) 2013;49(42):4830-2.
2013: Stephen M Bromfield; Maurizio Fermeglia; Paola Posocco; Pricl Sabrina; Anna Barnard; David K Smith
Mallard blue: a high-affinity selective heparin sensor that operates in highly competitive media.
Journal of the American Chemical Society 2013;135(8):2911-4.
2012: Erik Laurini; Maria Grazia Mamolo; Domenico Marson; Valentina Dal Col; Maurizio Fermeglia; Luciano Vio; Daniele Zampieri; Pricl Sabrina
Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.
Molecular pharmaceutics 2012;9(11):3107-26.
2012: Christina Meyer; Pricl Sabrina; Dirk Schepmann; Valentina Dal Col; Kenichiro Itami; Erik Laurini; Junichiro Yamaguchi; Shuichi Yanagisawa; Bernhard Wünsch
Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.
Journal of medicinal chemistry 2012;55(18):8047-65.
2012: Paola Posocco; Pricl Sabrina; Silvia Bidoggia; Maurizio Fermeglia; Paola Franchi; Cristina Gentilini; Marco Lucarini; Alice Pace; Lucia Pasquato
Self-organization of mixtures of fluorocarbon and hydrocarbon amphiphilic thiolates on the surface of gold nanoparticles.
ACS nano 2012;6(8):7243-53.
2012: Yi Xia; Fabio Ziarelli; Maurizio Fermeglia; Erik Laurini; Paola Posocco; Pricl Sabrina; Fanqi Qu; Stéphane Viel; Yang Wang; Ling Peng
Rationalizing the F···S interaction discovered within a tetrafluorophenylazido-containing bola-phospholipid.
Chemical communications (Cambridge, England) 2012;48(36):4284-6.
2012: Xiaoxuan Liu; Erik Laurini; Cheng Liu; Paola Posocco; Pricl Sabrina; Fanqi Qu; Palma Rocchi; Ling Peng
Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.
Molecular pharmaceutics 2012;9(3):470-81.
2012: K Karatasos; Erik Laurini; Paola Posocco; Pricl Sabrina
Poly(amidoamine)-based dendrimer/siRNA complexation studied by computer simulations: effects of pH and generation on dendrimer structure and siRNA binding.
Macromolecular bioscience 2012;12(2):225-40.
2012: Don L Gibbons; Pricl Sabrina; Jorge Cortes; Hagop Kantarjian; Alfonso Quintás-Cardama
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm.
Cancer 2012;118(2):293-9.
2012: P Posocco; V Dal Col; Maurizio Fermeglia; K Karatasos; E Laurini; D Marson; Pricl Sabrina
Tell me something I do not know. Multiscale molecular modeling of dendrimer/ dendron organization and self-assembly in gene therapy.
Current medicinal chemistry 2012;19(29):5062-87.
2011: Xiaoxuan Liu; Jiehua Zhou; Genevieve Victorero; Jean-Paul Behr; Maurizio Fermeglia; Jiangyu Wu; Patrick Erbacher; Cheng Liu; Pricl Sabrina; Miriam Yammine; Catherine Nguyen; Stephane Viel; Fabio Ziarelli; Paola Posocco; Ling Peng
Structurally flexible triethanolamine core PAMAM dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus.
Bioconjugate chemistry 2011;22(12):2461-73.
2011: Anna Barnard; Marcelo Calderon; Daniel W Pack; Paola Posocco; Victor W T Shum; Mark E Hwang; Pricl Sabrina; Rainer Haag; David K Smith
Degradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake.
Journal of the American Chemical Society 2011;133(50):20288-300.
2011: Antonio Carta; Antonietta Di Cristina; Maurizio Fermeglia; Stefania Grimaudo; Paolo La Colla; Erik Laurini; Roberta Loddo; Maria Silvia Paneni; Rosaria Maria Pipitone; Sandra Piras; Paola Posocco; Gianpiero Boatto; Irene Briguglio; Manlio Tolomeo; Pricl Sabrina
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors.
European journal of medicinal chemistry 2011;46(9):4151-67.
2011: Xinjun Liu; Han Chen; Erik Laurini; Yang Wang; Valentina Dal Col; Paola Posocco; Fabio Ziarelli; Maurizio Fermeglia; Cheng-Cai Zhang; Pricl Sabrina; Ling Peng
2-difluoromethylene-4-methylenepentanoic acid, a paradoxical probe able to mimic the signaling role of 2-oxoglutaric acid in cyanobacteria.
Organic letters 2011;13(11):2924-7.
2011: Simon P Jones; Nathan P Gabrielson; Chun-Ho Wong; Hak-Fun Chow; Daniel W Pack; Paola Posocco; Maurizio Fermeglia; Pricl Sabrina; David K Smith
Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection.
Molecular pharmaceutics 2011;8(2):416-29.
2011: Marco A Pierotti; Elena Tamborini; Tiziana Negri; Pricl Sabrina; Silvana Pilotti
Targeted therapy in GIST: in silico modeling for prediction of resistance.
Nature reviews. Clinical oncology 2011;8(3):161-70.
2011: Palma Dileo; Pricl Sabrina; Elena Tamborini; Tiziana Negri; Silvia Stacchiotti; Alessandro Gronchi; Paola Posocco; Erik Laurini; Paola Coco; Elena Fumagalli; Paolo G Casali; Silvana Pilotti
Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study.
International journal of cancer. Journal international du cancer 2011;128(4):983-90.
2010: Filomena Piscitelli; Paola Posocco; Radovan Toth; Maurizio Fermeglia; Pricl Sabrina; Giuseppe Mensitieri; Marino Lavorgna
Sodium montmorillonite silylation: unexpected effect of the aminosilane chain length.
Journal of colloid and interface science 2010;351(1):108-15.
2010: Gabriele Giliberti; Cristina Ibba; Esther Marongiu; Roberta Loddo; Michele Tonelli; Vito Boido; Erik Laurini; Paola Posocco; Maurizio Fermeglia; Pricl Sabrina
Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase.
Bioorganic & medicinal chemistry 2010;18(16):6055-68.
2010: Giovanni Maria Pavan; Paola Posocco; Aaron Tagliabue; Marek Maly; Anastasia Malek; Andrea Danani; Enzio Ragg; Carlo V Catapano; Pricl Sabrina
PAMAM dendrimers for siRNA delivery: computational and experimental insights.
Chemistry (Weinheim an der Bergstrasse, Germany) 2010;16(26):7781-95.
2010: Erik Laurini; Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Caterina Zanette; C Florio; Paola Posocco; Maurizio Fermeglia; Pricl Sabrina
A 3D-pharmacophore model for sigma2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Bioorganic & medicinal chemistry letters 2010;20(9):2954-7.
2010: Michele Tonelli; Matteo Simone; Bruno Tasso; Federica Novelli; Vito Boido; Fabio Sparatore; Giuseppe Paglietti; Pricl Sabrina; Gabriele Giliberti; Sylvain Blois; Cristina Ibba; Giuseppina Sanna; Roberta Loddo; Paolo La Colla
Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives.
Bioorganic & medicinal chemistry 2010;18(8):2937-53.
2010: Michele Tonelli; Vito Boido; Paolo La Colla; Roberta Loddo; Paola Posocco; Maria Silvia Paneni; Maurizio Fermeglia; Pricl Sabrina
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV).
Bioorganic & medicinal chemistry 2010;18(6):2304-16.
2010: Marco A Pierotti; Tiziana Negri; Elena Tamborini; Federica Perrone; Pricl Sabrina; Silvana Pilotti
Targeted therapies: the rare cancer paradigm.
Molecular oncology 2010;4(1):19-37.
2009: Antonio Carta; Pricl Sabrina; Sandra Piras; Maurizio Fermeglia; Paolo La Colla; Roberta Loddo
Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants.
European journal of medicinal chemistry 2009;44(12):5117-22.
2009: Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; C Florio; Caterina Zanette; Maurizio Fermeglia; Paola Posocco; Maria Silvia Paneni; Pricl Sabrina; Luciano Vio
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Journal of medicinal chemistry 2009;52(17):5380-93.
2009: Elena Conca; Tiziana Negri; Alessandro Gronchi; Elena Fumagalli; Elena Tamborini; Giovanni Maria Pavan; Maurizio Fermeglia; Marco A Pierotti; Pricl Sabrina; Silvana Pilotti
Activate and resist: L576P-KIT in GIST.
Molecular cancer therapeutics 2009;8(9):2491-5.
2009: Giulio Scocchi; Paola Posocco; Jan-Willem Handgraaf; Johannes G E M Fraaije; Maurizio Fermeglia; Pricl Sabrina
A complete multiscale modelling approach for polymer-clay nanocomposites.
Chemistry (Weinheim an der Bergstrasse, Germany) 2009;15(31):7586-92.
2009: Scott E Woodman; Jonathan Trent; Katherine Stemke-Hale; Alexander Lazar; Pricl Sabrina; Giovanni M Pavan; Maurizio Fermeglia; Y N Vashisht Gopal; Dan Yang; Donald A Podoloff; Doina Ivan; Kevin B Kim; Nicholas Papadopoulos; Patrick Hwu; Gordon B Mills; Michael A Davies
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
Molecular cancer therapeutics 2009;8(8):2079-85.
2009: Giovanni M Pavan; Andrea Danani; Pricl Sabrina; David K Smith
Modeling the multivalent recognition between dendritic molecules and DNA: understanding how ligand "sacrifice" and screening can enhance binding.
Journal of the American Chemical Society 2009;131(28):9686-94.
2009: Michele Tonelli; Iana Vazzana; Bruno Tasso; Vito Boido; Fabio Sparatore; Maurizio Fermeglia; Maria Silvia Paneni; Paola Posocco; Pricl Sabrina; Paolo La Colla; Cristina Ibba; Barbara Secci; Gabriella Collu; Roberta Loddo
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives.
Bioorganic & medicinal chemistry 2009;17(13):4425-40.
2009: Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Maurizio Fermeglia; Paola Posocco; Pricl Sabrina; Elena Banfi; Giuditta Scialino; Luciano Vio
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
Bioorganic & medicinal chemistry 2009;17(13):4693-707.
2009: Tiziana Negri; Giovanni Maria Pavan; Emanuela Virdis; Angela Greco; Maurizio Fermeglia; Marco Sandri; Pricl Sabrina; Marco A Pierotti; Silvana Pilotti; Elena Tamborini
T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense.
Journal of the National Cancer Institute 2009;101(3):194-204.
2008: Michele Tonelli; Vito Boido; Caterina Canu; Anna Sparatore; Fabio Sparatore; Maria Silvia Paneni; Maurizio Fermeglia; Pricl Sabrina; Paolo La Colla; Laura Casula; Cristina Ibba; David Collu; Roberta Loddo
Antimicrobial and cytotoxic arylazoenamines. Part III: antiviral activity of selected classes of arylazoenamines.
Bioorganic & medicinal chemistry 2008;16(18):8447-65.
2008: John C McAuliffe; Wei-Lein Wang; Giovanni M Pavan; Pricl Sabrina; Dan Yang; Su S Chen; Alexander Lazar; Raphael E Pollock; Jonathan Trent
Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors.
Molecular oncology 2008;2(2):161-3.
2008: Antonio Carta; Sandra Piras; Giuseppe Paglietti; Pricl Sabrina; Paolo La Colla; Bernardetta Busonera; Roberta Loddo
2(3)-Aryl-thio(oxy)-methylquinoxaline derivatives: a new class of P-glycoprotein-mediated drug efflux inhibitors.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2008;4(3):194-205.
2008: Angela Angusti; Stefano Manfredini; Elisa Durini; Nunzia Ciliberti; Silvia Vertuani; Nicola Solaroli; Pricl Sabrina; Marco Ferrone; Maurizio Fermeglia; Roberta Loddo; Barbara Secci; Anna Visioli; Tiziana Sanna; Gabriella Collu; Margherita Pezzullo; Paolo La Colla
Design, synthesis and anti flaviviridae activity of N(6)-, 5',3'-O- and 5',2'-O-substituted adenine nucleoside analogs.
Chemical & pharmaceutical bulletin 2008;56(4):423-32.
2008: Mauro Mazzei; Erika Nieddu; Monica Miele; Alessandro Balbi; Marco Ferrone; Maurizio Fermeglia; Marco T Mazzei; Pricl Sabrina; Paolo La Colla; Fabio Marongiu; Cristina Ibba; Roberta Loddo
Activity of Mannich bases of 7-hydroxycoumarin against Flaviviridae.
Bioorganic & medicinal chemistry 2008;16(5):2591-605.
2007: Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Elena Banfi; Giuditta Scialino; Maurizio Fermeglia; Marco Ferrone; Pricl Sabrina
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P450(14DM) by molecular docking and MM/PBSA method.
Bioorganic & medicinal chemistry 2007;15(23):7444-58.
2007: Antonio Carta; Mario Loriga; Sandra Piras; Giuseppe Paglietti; Marco Ferrone; Maurizio Fermeglia; Pricl Sabrina; Paolo La Colla; Gabriella Collu; T Sanna; Roberta Loddo
Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2007;3(6):520-32.
2007: Giulio Scocchi; Paola Posocco; Maurizio Fermeglia; Pricl Sabrina
Polymer-clay nanocomposites: a multiscale molecular modeling approach.
The journal of physical chemistry. B 2007;111(9):2143-51.
2007: Antonio Carta; Mario Loriga; Giuseppe Paglietti; Marco Ferrone; Maurizio Fermeglia; Pricl Sabrina; Tiziana Sanna; Cristina Ibba; Paolo La Colla; Roberta Loddo
Design, synthesis, and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against single-stranded positive-sense RNA genome viruses.
Bioorganic & medicinal chemistry 2007;15(5):1914-27.
2006: Pricl Sabrina; Marco Ferrone; Maurizio Fermeglia; Francesco Amato; Carlo Cosentino; Mark Ming-Cheng Cheng; Robert Walczak; Mauro Ferrari
Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations.
Biomedical microdevices 2006;8(4):277-90.
2006: Francesco Amato; Carlo Cosentino; Pricl Sabrina; Marco Ferrone; Maurizio Fermeglia; Mark Ming-Cheng Cheng; Robert Walczak; Mauro Ferrari
Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model.
Biomedical microdevices 2006;8(4):291-8.
2006: Antonio Carta; Giovanni Loriga; Sandra Piras; Giuseppe Paglietti; Marco Ferrone; Maurizio Fermeglia; Pricl Sabrina; Paolo La Colla; Barbara Secci; Gabriella Collu; Roberta Loddo
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2006;2(6):577-89.
2006: Elena Tamborini; Tiziana Negri; Francesca Miselli; M Stefania Lagonigro; Pricl Sabrina; Silvana Pilotti
Re: Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.
Journal of the National Cancer Institute 2006;98(21):1583-4.
2006: Elena Tamborini; Pricl Sabrina; Tiziana Negri; M Stefania Lagonigro; Francesca Miselli; Angela Greco; Alessandro Gronchi; Paolo G Casali; Marco Ferrone; Maurizio Fermeglia; Antonino Carbone; Marco A Pierotti; Silvana Pilotti
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.
Oncogene 2006;25(45):6140-6.
2006: Maurizio Fermeglia; Paolo Braiuca; Lucia Gardossi; Pricl Sabrina; Peter J Halling
In silico prediction of medium effects on esterification equilibrium using the COSMO-RS method.
Biotechnology progress 2006;22(4):1146-52.
2006: Elena Banfi; Giuditta Scialino; Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Marco Ferrone; Maurizio Fermeglia; Maria Silvia Paneni; Pricl Sabrina
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach.
The Journal of antimicrobial chemotherapy 2006;58(1):76-84.
2006: Marco Ferrone; Federica Perrone; Elena Tamborini; Maria Silvia Paneni; Maurizio Fermeglia; Simona Suardi; Elisa Pastore; Domenico Delia; Marco A Pierotti; Pricl Sabrina; Silvana Pilotti
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y).
Molecular cancer therapeutics 2006;5(6):1467-73.
2006: Radovan Toth; Marco Ferrone; Stanislav Miertus; Emo Chiellini; Maurizio Fermeglia; Pricl Sabrina
Structure and energetics of biocompatible polymer nanocomposite systems: a molecular dynamics study.
Biomacromolecules 2006;7(6):1714-9.
2005: Roberto Di Santo; Maurizio Fermeglia; Marco Ferrone; Maria Silvia Paneni; Roberta Costi; Marino Artico; Alessandra Roux; Mirko Gabriele; Keith D Tardif; Aleem Siddiqui; Pricl Sabrina
Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors.
Journal of medicinal chemistry 2005;48(20):6304-14.
2005: Pricl Sabrina; Maurizio Fermeglia; Marco Ferrone; Elena Tamborini
T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study.
Molecular cancer therapeutics 2005;4(8):1167-74.
2005: Maria Grazia Mamolo; Daniele Zampieri; Luciano Vio; Maurizio Fermeglia; Marco Ferrone; Pricl Sabrina; Giuditta Scialino; Elena Banfi
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations.
Bioorganic & medicinal chemistry 2005;13(11):3797-809.
2005: Elena Tamborini; Elisa Gabanti; M Stefania Lagonigro; Tiziana Negri; Silvana Pilotti; Marco A Pierotti; Pricl Sabrina
KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.
Cancer research 2005;65(3):1115; author reply 1115.
2004: Lorenzo Metullio; Marco Ferrone; Alessandro Coslanich; Sabine Fuchs; Maurizio Fermeglia; Maria Silvia Paneni; Pricl Sabrina
Polyamidoamine (Yet Not PAMAM) dendrimers as bioinspired materials for drug delivery: structure-activity relationships by molecular simulations.
Biomacromolecules 2004;5(4):1371-8.
2004: Vladimir Frecer; Martin Kabelác; Piergiuseppe De Nardi; Pricl Sabrina; Stanislav Miertus
Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
Journal of molecular graphics & modelling 2004;22(3):209-20.
2003: Paolo Caliceti; Stefano Salmaso; Alessandra Semenzato; Tommaso Carofiglio; Roberto Fornasier; Maurizio Fermeglia; Marco Ferrone; Pricl Sabrina
Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery.
Bioconjugate chemistry 2003;14(5):899-908.
2003: Stefano Manfredini; Nicola Solaroli; Angela Angusti; Federico Nalin; Elisa Durini; Silvia Vertuani; Pricl Sabrina; Marco Ferrone; Silvio Spadari; Federico Focher; Annalisa Verri; Erik De Clercq; Jan Balzarini
Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity.
Antiviral chemistry & chemotherapy 2003;14(4):183-94.
2002: Maurizio Fermeglia; Marco Ferrone; Pricl Sabrina
Computer-aided simulation of a dendrimer with a protoporphyrinic core as potential, novel hemoprotein mimic.
Bioorganic & medicinal chemistry 2002;10(8):2471-8.
1997: G Copetti; Mario Grassi; R Lapasin; Pricl Sabrina
Synergistic gelation of xanthan gum with locust bean gum: a rheological investigation.
Glycoconjugate journal 1997;14(8):951-61.
1990: F Delben; R Lapasin; Pricl Sabrina
Flow properties of N-(carboxymethyl) chitosan aqueous systems in the sol and gel domains.
International journal of biological macromolecules 1990;12(1):9-13.